Clinical Trial: Sotorasib Plus Panitumumab in KRAS p.G12C-Mutated Metastatic Colorectal Cancer
Researchers are conducting a phase 3 trial to compare sotorasib plus panitumumab with investigator’s choice of therapy in patients with previously treated, KRAS p.G12C-mutated metastatic colorectal cancer.